Champions Oncology (CSBR) EBIT (QoQ) (2010 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -89.13% |
| Jan 31, 2026 | -249.19% |
| Oct 31, 2025 | 135.10% |
| Jul 31, 2025 | 73.74% |
| Apr 30, 2025 | -144.61% |
| Jan 31, 2025 | 514.62% |
| Oct 31, 2024 | -44.92% |
| Jul 31, 2024 | 590.41% |
| Apr 30, 2024 | 89.48% |
| Jan 31, 2024 | -31.82% |
| Oct 31, 2023 | 23.39% |
| Jul 31, 2023 | -1.23% |
| Apr 30, 2023 | -2.56% |
| Jan 31, 2023 | -35,214.29% |
| Oct 31, 2022 | 102.46% |
| Jul 31, 2022 | 8.68% |
| Apr 30, 2022 | -137.47% |
| Jan 31, 2022 | 215.59% |
| Oct 31, 2021 | 250.29% |
| Jul 31, 2021 | 72.99% |